These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 21958537)

  • 1. Gel formulations containing catanionic vesicles composed of alprenolol and SDS: effects of drug release and skin penetration on aggregate structure.
    Dew N; Edwards K; Eriksson J; Edsman K; Björk E
    Colloids Surf B Biointerfaces; 2012 Jan; 89():53-60. PubMed ID: 21958537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel gel formulations with catanionic aggregates enable prolonged drug release and reduced skin permeation.
    Dew N; Edsman K; Björk E
    J Pharm Pharmacol; 2011 Oct; 63(10):1265-73. PubMed ID: 21899541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gel formation in systems composed of drug containing catanionic vesicles and oppositely charged hydrophobically modified polymer.
    Dew N; Edwards K; Edsman K
    Colloids Surf B Biointerfaces; 2009 May; 70(2):187-97. PubMed ID: 19167869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catanionic aggregates formed from drugs and lauric or capric acids enable prolonged release from gels.
    Dew N; Bramer T; Edsman K
    J Colloid Interface Sci; 2008 Jul; 323(2):386-94. PubMed ID: 18479696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catanionic mixtures involving a drug: a rather general concept that can be utilized for prolonged drug release from gels.
    Bramer T; Dew N; Edsman K
    J Pharm Sci; 2006 Apr; 95(4):769-80. PubMed ID: 16498573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of regular solution theory on the release mechanism of catanionic mixtures from gels.
    Bramer T; Frenning G; Gråsjö J; Edsman K; Hansson P
    Colloids Surf B Biointerfaces; 2009 Jul; 71(2):214-25. PubMed ID: 19286357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catanionic drug-surfactant mixtures: phase behavior and sustained release from gels.
    Bramer T; Paulsson M; Edwards K; Edsman K
    Pharm Res; 2003 Oct; 20(10):1661-7. PubMed ID: 14620523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of permeation enhancers on the iontophoretic transport of metoprolol tartrate and the drug retention in skin.
    Nair A; Vyas H; Shah J; Kumar A
    Drug Deliv; 2011 Jan; 18(1):19-25. PubMed ID: 20726811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical drug delivery by a polymeric nanosphere gel: Formulation optimization and in vitro and in vivo skin distribution studies.
    Batheja P; Sheihet L; Kohn J; Singer AJ; Michniak-Kohn B
    J Control Release; 2011 Jan; 149(2):159-67. PubMed ID: 20950659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced local anesthetic action of mepivacaine from the bioadhesive gels.
    Cho CW; Choi JS; Shin SC
    Pak J Pharm Sci; 2011 Jan; 24(1):87-93. PubMed ID: 21190925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of original bioactive formulations based on sugar-surfactant/non-steroidal anti-inflammatory catanionic self-assemblies: a new way of dermal drug delivery.
    Consola S; Blanzat M; Perez E; Garrigues JC; Bordat P; Rico-Lattes I
    Chemistry; 2007; 13(11):3039-47. PubMed ID: 17285653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrodynamic investigations of ion transport and structural properties in drug-containing gels: dielectric spectroscopy and transient current measurements on catanionic carbopol systems.
    Brohede U; Bramer T; Edsman K; Strømme M
    J Phys Chem B; 2005 Aug; 109(32):15250-5. PubMed ID: 16852931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy study of vesicular gel containing methotrexate and menthol combination on parakeratotic rat skin model.
    Nagle A; Goyal AK; Kesarla R; Murthy RR
    J Liposome Res; 2011 Jun; 21(2):134-40. PubMed ID: 20557280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human skin penetration and distribution of nimesulide from hydrophilic gels containing nanocarriers.
    Alves MP; Scarrone AL; Santos M; Pohlmann AR; Guterres SS
    Int J Pharm; 2007 Aug; 341(1-2):215-20. PubMed ID: 17482392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of drug/surfactant catanionic vesicles and their application in sustained drug release.
    Jiang Y; Li F; Luan Y; Cao W; Ji X; Zhao L; Zhang L; Li Z
    Int J Pharm; 2012 Oct; 436(1-2):806-14. PubMed ID: 22871561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel gel phase formed by mixing a cationic surfactive ionic liquid C(16)mimCl and an anionic surfactant SDS in aqueous solution.
    Zhao Y; Chen X; Jing B; Wang X; Ma F
    J Phys Chem B; 2009 Jan; 113(4):983-8. PubMed ID: 19125577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of tolnaftate release from fatty acids containing ointment and penetration into human skin ex vivo.
    Kezutyte T; Drevinskas T; Maruska A; Rimdeika R; Briedis V
    Acta Pol Pharm; 2011; 68(6):965-73. PubMed ID: 22125963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temoporfin-loaded liposomal gels: viscoelastic properties and in vitro skin penetration.
    Dragicevic-Curic N; Winter S; Stupar M; Milic J; Krajisnik D; Gitter B; Fahr A
    Int J Pharm; 2009 May; 373(1-2):77-84. PubMed ID: 19429291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C12mimBr ionic liquid/SDS vesicle formation and use as template for the synthesis of hollow silica spheres.
    Yuan J; Bai X; Zhao M; Zheng L
    Langmuir; 2010 Jul; 26(14):11726-31. PubMed ID: 20527834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of penetration enhancers on in vitro percutaneous penetration of nimesulide through rat skin.
    Güngör S; Bergişadi N
    Pharmazie; 2004 Jan; 59(1):39-41. PubMed ID: 14964420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.